Clinics in Dermatology
Volume 25, Issue 2 , Pages 195-202 , March 2007

Mycetoma

  • Oliverio Welsh, MD

      Affiliations

    • Dermatology Department, University Hospital, UANL, Monterrey, NL 64460, México
    • Corresponding Author InformationCorresponding author.
    • ,
  • Lucio Vera-Cabrera (DrSc)

      Affiliations

    • Dermatology Department, University Hospital, UANL, Monterrey, NL 64460, México
    • ,
  • Mario Cesar Salinas-Carmona, MD

      Affiliations

    • Immunology Department, Medical School, UANL, Monterrey, NL 64460, México

References 

  1. Lavalle P. New data on the etiology of mycetoma in Mexico and on its pathogenesis. Gac Med Mex. 1966;96:545–574
  2. Lopez Martinez R, Mendez Tovar LJ, Lavalle P, Welsh O, Saul A, Macotela Ruiz E. Epidemiology of mycetoma in Mexico: study of 2105 cases. Gac Med Mex. 1992;128:477–481
  3. Mahgoub ES, Murray IG. In: Mycetoma. London: Williams Heinemann Medical Books; 1973;p. 115
  4. Mariat F, Destombes P, Segretain G. The mycetomas: clinical features, pathology, etiology and epidemiology. Contrib Microbiol Immunol. 1977;4:1–39
  5. Ndiaye B, Develoux M, Langlade MA, Kane A. Actinomycotic mycetoma. Apropos of 27 cases in Dakar; medical treatment with cotrimoxazole. Ann Dermatol Venereol. 1994;121:161–165
  6. Develoux M, Ndiaye B, Dieng MT. Mycetomas in Africa. Sante. 1995;5:211–217
  7. Rodriguez-Nava V, Couble A, Molinard C, Sandoval H, Boiron P, Laurent F. Nocardia mexicana sp. nov., a new pathogen isolated from human mycetomas. J Clin Microbiol. 2004;42:4530–4535
  8. Bakker XR, Spauwen PH, Dolmans WM. Mycetoma of the hand caused by Gordona terrae: a case report. J Hand Surg [Br]. 2004;29:188–190
  9. Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004;4:566–574
  10. Welsh O, Salinas MC, Rodriguez MA. Mycetoma. In:  Hoeprich PD,  Jordan MC,  Ronald AR editor. Infectious disease. 5th ed.. Philadelphia (Pa): J.B. Lippincott Co; 1994;p. 1405
  11. Beaman BL, Saubolle MA, Wallace RJ. Nocardia, Rhodococcus, Streptomyces, Oerskovia, and other aerobic Actinomycetes of medical importance. In:  Murray PR,  Baron EJ,  Pfaller MA,  Tenover FC,  Yolken RH editor. Manual of clinical microbiology. 6th ed.. Washington (DC): ASM Press; 1995;p. 379–397
  12. Muir DB, Pritchard RC. Use of the BioMerieux ID 32C yeast identification system for identification of aerobic actinomycetes of medical importance. J Clin Microbiol. 1997;35:3240–3243
  13. Butler WR, Kilburn JO, Kubica GP. High-performance liquid chromatography analysis of mycolic acids as an aid in laboratory identification of Rhodococcus and Nocardia species. J Clin Microbiol. 1987;25:2126–3131
  14. Patel JB, Wallace RJ, Brown-Elliott BA, et al. Sequence-based identification of aerobic actinomycetes. J Clin Microbiol. 2004;42:2530–2540
  15. Kano R, Hattori Y, Murakami N, et al. The first isolation of Nocardia veterana from a human mycetoma. Microbiol Immunol. 2002;46:409–412
  16. Trujillo ME, Goodfellow M. Polyphasic taxonomic study of clinically significant actinomadurae including the description of Actinomadura latina sp. nov. Zentralbl Bakteriol. 1997;285:212–333
  17. Salinas-Carmona MC, Welsh O, Casillas SM. Enzyme-linked immunosorbent assay for serological diagnosis of Nocardia brasiliensis and clinical correlation with mycetoma infections. J Clin Microbiol. 1993;31:2901–2906
  18. Yera H, Bougnoux ME, Jeanrot C, Baixench MT, De Pinieux G, Dupouy-Camet J. Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J Clin Microbiol. 2003;41:1805–1808
  19. Fahal AH, Sheik HE, Homeida MM, Arabi YE, Mahgoub ES. Ultrasonographic imaging of mycetoma. Br J Surg. 1997;84:1120–1122
  20. Ganguli SN, Hershkop M. Bone scintigraphy of Madura foot. Clin Nucl Med. 1999;24:284–285
  21. Czechowski J, Nork M, Haas D, Lestringant G, Ekelund L. MR and other imaging methods in the investigation of mycetomas. Acta Radiol. 2001;42:24–26
  22. Melendro El, Contreras MF, Ximenez C, Garcia-Maynez AM, Ortiz-Ortiz L. Changes in host resistance caused by Nocardia brasiliensis in mice: cross-protection against Listeria monocytogenes. Int Arch Allergy Appl Immunol. 1978;57:74–81
  23. Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7:213–264
  24. Beaman BL, Goldstein E, Gershwin ME, Maslan S, Lippert W. Lung response to congenitally athymic (nude), heterozygous, and Swiss Webster mice to aerogenic and intranasal infection by Nocardia asteroides. Infect Immun. 1978;22:867–877
  25. Vera-Cabrera L, Rodriguez-Quintanilla MA, Boiron P, Salinas-Carmona MC, Welsh O. Experimental mycetoma by Nocardia brasiliensis in rats. J Mycol Med. 1998;8:183–187
  26. Kaufmann SHE. Immunity to intracelullar bacteria. Annu Rev Immunol. 1993;11:129–163
  27. Deem RL, Doughty FA, Beeman BL. Immunologically specific direct T lymphocyte mediated killing of Nocardia asteroides. J Immunol. 1983;130:2401–2406
  28. Mahgoub ES, Gumaa SA, EL Hassan AM. Immunological status of mycetoma patients. Bull Soc Pathol Exot Filiales. 1977;70:48–54
  29. Gonzalez Ochoa A, Baranda F. A cutaneous test for diagnosis of actinomycotic mycetoma caused by Nocardia brasiliensis. Rev Inst Salubr Enferm Trop. 1953;13:189–197
  30. Salinas-Carmona MC, Pérez-Rivera I. Humoral immunity through IgM protects mice from an experimental actinomycetoma infection by Nocardia brasiliensis. Infect Immun. 2004;72:5597–5604
  31. Beaman BL, Gershwin ME, Ahmed A, Scates SM, Deem R. Response of CBA/N × DBA2/F1 mice to Nocardia asteroides. Infect Immun. 1982;35:111–116
  32. Angeles AM, Sugar AM. Identification of a common immunodominant protein in culture filtrates of three Nocardia species and use in etiologic diagnosis of mycetoma. J Clin Microbiol. 1987;25:2278–2280
  33. Angeles AM, Sugar AM. Rapid diagnosis of nocardiosis with an enzyme immunoassay. J Infect Dis. 1987;155:292–296
  34. Ortiz-Ortiz L, Bojalil LF. Delayed skin reactions to cytoplasmic extracts of Nocardia organisms as a means of diagnosis and epidemiological study of Nocardia infection. Clin Exp Immunol. 1972;12:225–229
  35. Ortiz-Ortiz L, Bojalil LF, Contreras MF. Delayed hypersensitivity to polysaccharides from Nocardia. J Immunol. 1972;108:1409–1413
  36. Welsh O. Mycetoma. Int J Dermatol. 1991;30:387–398
  37. Mahgoub ES. Medical management of mycetoma. Bull World Health Organ. 1976;54:303–310
  38. Gomez A, Saul A, Bonifaz A, Lopez M. Amoxicillin and clavulanic acid in the treatment of actinomycetoma. Int J Dermatol. 1993;32:218–220
  39. Welsh O, Sauceda E, Gonzalez J, Ocampo J. Amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of actinomycotic mycetoma. J Am Acad Dermatol. 1987;17:443–448
  40. Wallace RJ, Septimus EJ, Musher DM, Martin RR. Disk diffusion susceptibility testing of Nocardia species. J Infect Dis. 1977;135:568–576
  41. Wilson RW, Steingrube VA, Brown BA, et al. Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis. J Clin Microbiol. 1997;35:2235–2242
  42. Vera-Cabrera L, Gomez-Flores A, Escalante-Fuentes WG, Welsh O. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemother. 2001;45:3629–3630
  43. Gomez-Flores A, Welsh O, Said-Fernandez S, Lozano-Garza G, Tavarez-Alejandro RE, Vera-Cabrera L. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother. 2004;48:832–837
  44. Moylett EH, Pacheco SE, Brown-Elliott BA, et al. Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis. 2003;36:313–318
  45. Vera-Cabrera L, Gonzalez E, Choi SH, Welsh O. In vitro activities of new antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother. 2004;48:602–604
  46. Vera-Cabrera L, Ochoa-Felix EY, Gonzalez G, Tijerina R, Choi SH, Welsh O. In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae. Antimicrob Agents Chemother. 2004;48:1037–1039
  47. Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis. 2002;34:1648–1650
  48. Gonzalez GM, Tijerina R, Najvar LK, et al. Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays. Antimicrob Agents Chemother. 2003;47:1436–1438
  49. Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol. 1999;(Suppl 56):36–40
  50. Paugam A, Tourte-Schaefer C, Keita A, Chemla N, Chevrot A. Clinical cure of fungal Madura foot with oral itraconazole. Cutis. 1997;60:191–193
  51. Lacroix C, de Kerviler E, Morel P, Derouin F, Feuilhade de Chavin M. Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol. 2005;152:1067–1068
  52. Ahmed AO, van de Sande WW, van Vianen W, et al. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother. 2004;48:2742–2746

PII: S0738-081X(06)00070-8

doi: 10.1016/j.clindermatol.2006.05.011

Clinics in Dermatology
Volume 25, Issue 2 , Pages 195-202 , March 2007

Article Tools

* Image Usage & Resolution